Who's Watching The Watchmen This Time? The Mystery Of The New IRB Sting
Institutional review boards appear to be facing vigilante regulation as FDA warns that someone is submitting fictitious studies for review.
Institutional review boards appear to be facing vigilante regulation as FDA warns that someone is submitting fictitious studies for review.